BioAssets Development Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $42.5M

BioAssets Development General Information

Description

Producer of biologic drugs to treat the cause of pain in spinal disorders. The company also offers collaborations to maximize the value of partners' strategic assets by expanding the indications of biologic drugs.

Contact Information

Website
www.biodevco.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 888 Worcester Street
  • Suite 95
  • Wellesley, MA 02482
  • United States
+1 (339)
Primary Industry
Biotechnology
Acquirer
Cephalon
Vertical(s)
Life Sciences
Corporate Office
  • 888 Worcester Street
  • Suite 95
  • Wellesley, MA 02482
  • United States
+1 (339)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAssets Development Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Oct-2010 $42.5M Completed Generating Revenue
1. Seed Round 03-Sep-2009 Completed Generating Revenue
To view BioAssets Development’s complete valuation and funding history, request access »

BioAssets Development Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

BioAssets Development Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080019969-A1 Methods for preventing, postponing or improving the outcome of invasive spinal procedures Inactive 07-Jul-2006
US-20080019970-A1 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures Inactive 07-Jul-2006
CA-2692428-A1 Methods for preventing, postponing or improving the outcome of invasive spinal procedures Inactive 07-Jul-2006
CA-2697784-A1 Novel regimens for treating diseases and disorders Inactive 07-Jul-2006
CA-2692430-A1 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures Inactive 07-Jul-2006 A61K31/4164
To view BioAssets Development’s complete patent history, request access »

Ready to get started?

Request a free trial

BioAssets Development FAQs

  • When was BioAssets Development founded?

    BioAssets Development was founded in 2005.

  • Where is BioAssets Development headquartered?

    BioAssets Development is headquartered in Wellesley, MA.

  • What industry is BioAssets Development in?

    BioAssets Development’s primary industry is Biotechnology.

  • Is BioAssets Development a private or public company?

    BioAssets Development is a Private company.

  • What is the current valuation of BioAssets Development?

    The current valuation of BioAssets Development is .

  • What is BioAssets Development’s current revenue?

    The current revenue for BioAssets Development is .

  • How much funding has BioAssets Development raised over time?

    BioAssets Development has raised $4.71M.

  • When was BioAssets Development acquired?

    BioAssets Development was acquired on 21-Oct-2010.

  • Who acquired BioAssets Development?

    BioAssets Development was acquired by Cephalon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »